Keywords: gtc, completes, bla, filing, atryn, biotherapeutics, completed

GTC completes BLA filing for ATryn

Article | 18 August 2008

Print This

GTC Biotherapeutics has completed its submission of the final portion of the Biologics License Application, for ATryn, a recombinant form ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in